发明名称 PREVENTION AND MEASURE FOR MITOCHONDRIAL DISEASE
摘要 <p>A drug capable of treating mitochondrial disease, a disease causing various symptoms due to the dysfunction of mitochondria of the cells, which drug comprises L-arginine and, per part by weight of L-arginine, 0.2 to 20 parts by weight of L-ascorbic acid optionally together with at least one member selected from the group consisting of ribonucleic acids, ribonucleotides and ribonucleosides. The L-arginine contained in the drug for mitochondrial disease treatment increases the concentration of NO radicals to thereby enlarge the artery. The harsh taste and harsh feeling caused by the intake of L-arginine are relieved by the L-ascorbic acid. Further, any excess NO radicals are also deleted by the L-ascorbic acid.</p>
申请公布号 WO2005084660(A1) 申请公布日期 2005.09.15
申请号 WO2004JP02787 申请日期 2004.03.05
申请人 MORISHIGE, FUMIE;MORISHIGE, FUKUMI 发明人 MORISHIGE, FUKUMI
分类号 A61K31/198;A61K31/375;A61P43/00;(IPC1-7):A61K31/198 主分类号 A61K31/198
代理机构 代理人
主权项
地址